Search Results 581-590 of 30942 for Ovarian
Mayo Clinic researchers capture first signs of ovarian cancer risk featured image. Research. Mayo Clinic researchers capture first signs of ovarian cancer risk.
Paul Haluska, M.D., Palliation of ovarian cancer ascites via PAPP-A inhibition and repositioning antimalarial drug quinacrine to enhance carboplatin sensitivity ...
... ovarian cancer, including clinical trials. Cancer. Mayo Clinic Q&A podcast: Consider all treatment options for ovarian cancer, including clinical trials.
With a healthy pregnancy, an egg fertilized by sperm develops into the earliest form of an unborn baby, called an embryo. But with an anembryonic pregnancy, an ...
Word cloud illustration of ovarian diseases. Cancer. Media Expert Alert ... This is in light of actress Angelina Jolie's announcement she had her ovaries and ...
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor ...
Patients with advanced ovarian cancer that has not progressed following completion of standard-of-care chemotherapy are eligible to participate. Patients will ...
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.